Human Metabolome Technologies, Inc. (TYO:6090)
Japan · Delayed Price · Currency is JPY 606.00
+2.00 (0.33%)
Sep 16, 2026, 3:04 PM JST
TYO:6090 Market Cap
TYO:6090 has a market cap or net worth of 3.36 billion as of September 15, 2026. Its market cap has decreased by -19.46% in one year.
Market Cap
3.36B
Enterprise Value
2.02B
Revenue
1.42B
Ranking
n/a
PE Ratio
16.95
Stock Price
606.00
ChartMarket Cap Chart
Since December 24, 2013, TYO:6090's market cap has decreased from 11.04B to 3.36B, a decrease of -69.56%. That is a compound annual growth rate of -8.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 3.36B | -10.05% |
| Dec 30, 2025 | 3.74B | 2.79% |
| Dec 30, 2024 | 3.63B | -4.00% |
| Dec 29, 2023 | 3.79B | -5.61% |
| Dec 30, 2022 | 4.01B | 5.39% |
| Dec 30, 2021 | 3.81B | -13.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TMS Co., Ltd. | 5.66B |
| Soiken Holdings | 5.57B |
| Chordia Therapeutics | 5.33B |
| D. Western Therapeutics Institute | 5.01B |
| Ribomic | 4.58B |
| Kohjin Bio | 4.30B |
| Transgenic Group | 4.25B |
| Kringle Pharma | 3.77B |